NO128962B - - Google Patents
Download PDFInfo
- Publication number
- NO128962B NO128962B NO00603/69A NO60369A NO128962B NO 128962 B NO128962 B NO 128962B NO 00603/69 A NO00603/69 A NO 00603/69A NO 60369 A NO60369 A NO 60369A NO 128962 B NO128962 B NO 128962B
- Authority
- NO
- Norway
- Prior art keywords
- group
- compounds
- carbon atoms
- general formula
- stands
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 52
- 125000004432 carbon atom Chemical group C* 0.000 claims description 39
- 238000000034 method Methods 0.000 claims description 26
- -1 hydroxy- Chemical class 0.000 claims description 25
- 125000000217 alkyl group Chemical group 0.000 claims description 24
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 16
- 125000003545 alkoxy group Chemical group 0.000 claims description 16
- 239000000460 chlorine Substances 0.000 claims description 16
- 229910052801 chlorine Inorganic materials 0.000 claims description 16
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 15
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 15
- 229910052794 bromium Inorganic materials 0.000 claims description 15
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 14
- 229910052731 fluorine Inorganic materials 0.000 claims description 14
- 239000011737 fluorine Substances 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical class C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 claims description 11
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 8
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 7
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 7
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 5
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 4
- 125000004414 alkyl thio group Chemical group 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 4
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims description 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 229910052727 yttrium Inorganic materials 0.000 claims description 3
- 239000012345 acetylating agent Substances 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 60
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 42
- 239000000203 mixture Substances 0.000 description 34
- 239000000243 solution Substances 0.000 description 28
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 27
- 238000001953 recrystallisation Methods 0.000 description 26
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 20
- 238000002844 melting Methods 0.000 description 20
- 230000008018 melting Effects 0.000 description 20
- 239000012074 organic phase Substances 0.000 description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 14
- 239000002904 solvent Substances 0.000 description 13
- 239000007858 starting material Substances 0.000 description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 239000003960 organic solvent Substances 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- 238000009835 boiling Methods 0.000 description 7
- 238000001704 evaporation Methods 0.000 description 7
- 230000008020 evaporation Effects 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- 229910052938 sodium sulfate Inorganic materials 0.000 description 7
- 235000011152 sodium sulphate Nutrition 0.000 description 7
- 239000011592 zinc chloride Substances 0.000 description 7
- 235000005074 zinc chloride Nutrition 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 150000003388 sodium compounds Chemical class 0.000 description 5
- 239000012312 sodium hydride Substances 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000002480 mineral oil Substances 0.000 description 4
- 235000010446 mineral oil Nutrition 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- AJFDBNQQDYLMJN-UHFFFAOYSA-N n,n-diethylacetamide Chemical compound CCN(CC)C(C)=O AJFDBNQQDYLMJN-UHFFFAOYSA-N 0.000 description 3
- MZPDVYDLHYUTQS-UHFFFAOYSA-N (2-amino-5-methylphenyl)-phenylmethanone Chemical compound CC1=CC=C(N)C(C(=O)C=2C=CC=CC=2)=C1 MZPDVYDLHYUTQS-UHFFFAOYSA-N 0.000 description 2
- MAOBFOXLCJIFLV-UHFFFAOYSA-N (2-aminophenyl)-phenylmethanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC=C1 MAOBFOXLCJIFLV-UHFFFAOYSA-N 0.000 description 2
- HRPHZUAPQWJPCZ-UHFFFAOYSA-N (2-chloro-5-nitrophenyl)-phenylmethanone Chemical compound [O-][N+](=O)C1=CC=C(Cl)C(C(=O)C=2C=CC=CC=2)=C1 HRPHZUAPQWJPCZ-UHFFFAOYSA-N 0.000 description 2
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- AWAVJMREBRKGOY-UHFFFAOYSA-N [2-(ethylamino)-5-(trifluoromethyl)phenyl]-phenylmethanone Chemical compound CCNC1=CC=C(C(F)(F)F)C=C1C(=O)C1=CC=CC=C1 AWAVJMREBRKGOY-UHFFFAOYSA-N 0.000 description 2
- VLEZORDMPZZAFA-UHFFFAOYSA-N [2-(ethylamino)-5-nitrophenyl]-phenylmethanone Chemical compound CCNC1=CC=C([N+]([O-])=O)C=C1C(=O)C1=CC=CC=C1 VLEZORDMPZZAFA-UHFFFAOYSA-N 0.000 description 2
- QMHAHUAQAJVBIW-UHFFFAOYSA-N [methyl(sulfamoyl)amino]methane Chemical compound CN(C)S(N)(=O)=O QMHAHUAQAJVBIW-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229940111759 benzophenone-2 Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 2
- 239000002178 crystalline material Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- GZYBWMKOQXCCHC-UHFFFAOYSA-N (2-amino-5-methylsulfanylphenyl)-phenylmethanone Chemical compound CSC1=CC=C(N)C(C(=O)C=2C=CC=CC=2)=C1 GZYBWMKOQXCCHC-UHFFFAOYSA-N 0.000 description 1
- UFBFCUNAXFUILT-UHFFFAOYSA-N 1-phenylquinazolin-2-one Chemical compound O=C1N=CC2=CC=CC=C2N1C1=CC=CC=C1 UFBFCUNAXFUILT-UHFFFAOYSA-N 0.000 description 1
- OKDGPOCKHMGDQY-UHFFFAOYSA-N 3,4-dihydropyrrol-2-one Chemical compound O=C1CCC=N1 OKDGPOCKHMGDQY-UHFFFAOYSA-N 0.000 description 1
- FHUBTSLLILWICW-UHFFFAOYSA-N 4-phenyl-1h-quinazolin-2-one Chemical compound C12=CC=CC=C2NC(=O)N=C1C1=CC=CC=C1 FHUBTSLLILWICW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- DILPRJPRBYHSDX-UHFFFAOYSA-N CCC(C(N)=CC([N+]([O-])=O)=C1)=C1C(C1=CC=CC=C1)=O Chemical compound CCC(C(N)=CC([N+]([O-])=O)=C1)=C1C(C1=CC=CC=C1)=O DILPRJPRBYHSDX-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QHDJJBSLUFDASY-UHFFFAOYSA-N [2-chloro-5-(trifluoromethyl)phenyl]-phenylmethanone Chemical compound FC(F)(F)C1=CC=C(Cl)C(C(=O)C=2C=CC=CC=2)=C1 QHDJJBSLUFDASY-UHFFFAOYSA-N 0.000 description 1
- KIYLOYFQTWNSLH-UHFFFAOYSA-N [5-nitro-2-(propan-2-ylamino)phenyl]-phenylmethanone Chemical compound CC(C)NC1=CC=C([N+]([O-])=O)C=C1C(=O)C1=CC=CC=C1 KIYLOYFQTWNSLH-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001339 alkali metal compounds Chemical class 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001347 alkyl bromides Chemical class 0.000 description 1
- 125000005910 alkyl carbonate group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 244000243234 giant cane Species 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- FMKOJHQHASLBPH-UHFFFAOYSA-N isopropyl iodide Chemical compound CC(C)I FMKOJHQHASLBPH-UHFFFAOYSA-N 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 150000003112 potassium compounds Chemical class 0.000 description 1
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- YORCIIVHUBAYBQ-UHFFFAOYSA-N propargyl bromide Chemical compound BrCC#C YORCIIVHUBAYBQ-UHFFFAOYSA-N 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- KEAYESYHFKHZAL-BJUDXGSMSA-N sodium-22 Chemical compound [22Na] KEAYESYHFKHZAL-BJUDXGSMSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000004001 thioalkyl group Chemical group 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
hvori R står for fluor, klor eller brom, en alkylgruppe,'med. ,1-5 karbonatomer, en alkoksygruppe med 1 - h karbonatomer, en alkyMo-gruppe med 1- k karbonatomer, hydroksy-, nitro-, amino-, cyano-, acetamido-, trifluormetyl- 'eller merkapto-gruppen og n står for 1 eller 2 idet, in which R stands for fluorine, chlorine or bromine, an alkyl group,'med. ,1-5 carbon atoms, an alkoxy group with 1-h carbon atoms, an alkyMo group with 1-k carbon atoms, the hydroxy-, nitro-, amino-, cyano-, acetamido-, trifluoromethyl-' or mercapto group and n stands for 1 or 2 while,
1) hvis n står for 1, har R en annen betydning enn fluor,' 1) if n stands for 1, R has a meaning other than fluorine,'
klor eller brom, og chlorine or bromine, and
2) hvis n står for 2, er begge.R like eller forskjellige og 2) if n stands for 2, both.R are equal or different and
står for en alkylgruppe med 1-5 karbonatomer, en alkoksygruppe med 1 - U- karbonatomer eller for fluor, klor eller brom, stands for an alkyl group with 1-5 carbon atoms, an alkoxy group with 1 - U carbon atoms or for fluorine, chlorine or bromine,
R^ betyr en:alkylgruppe med 1-5 karbonatomer, allyl- eller proparyl-gruppen, idet R^ bare står for isopropyl-gruppen når n = 1 og R betyr hydroksy-, amino-, cyano-, acetamido- eiler merkaptogruppen og R2 står for fenyl eller en gruppe med den alminnelige formel II R^ means an alkyl group with 1-5 carbon atoms, the allyl or proparyl group, R^ only standing for the isopropyl group when n = 1 and R means hydroxy, amino, cyano, acetamido, or the mercapto group and R2 stands for phenyl or a group of the general formula II
hvor Y betyr fluor, klor eller brom, en alkylgruppe med 1- h karbonatomer, en alkoksygruppe med 1karbonatomer eller trifluormetylgruppen og Y1 betyr hydrogen, fluor, klor eller brom, where Y means fluorine, chlorine or bromine, an alkyl group with 1-h carbon atoms, an alkoxy group with 1 carbon atoms or the trifluoromethyl group and Y1 means hydrogen, fluorine, chlorine or bromine,
en alkylgruppe med 1- k karbonatomer eller en alkoksygruppe med 1- h karbonatomer, idet Y og Y^ ikke står for alkoksygruppen når R betyr hydroksy-eler merkapto-gruppen, an alkyl group with 1-k carbon atoms or an alkoxy group with 1-h carbon atoms, where Y and Y^ do not stand for the alkoxy group when R means the hydroxy or mercapto group,
Det særegne ved fremgangsmåten i henhold til oppfinnelsen er at The peculiarity of the method according to the invention is that
for fremstilling av forbindelser med den alminnelige formel Ia , for the preparation of compounds of the general formula Ia,
hvori R' står for fluor, klor eller brom, en alkylgruppe med 1-5 karbonatomer, en alkoksygruppe med 1- h karbonatomer, en alkyltiogruppe med 1-V karbonatomer, nitro-, cyano-, acetamid-, eller trifluormetyl-gruppen og n står for 1 eller 2 idet, in which R' stands for fluorine, chlorine or bromine, an alkyl group with 1-5 carbon atoms, an alkoxy group with 1-h carbon atoms, an alkylthio group with 1-V carbon atoms, the nitro-, cyano-, acetamide, or trifluoromethyl group and n stands for 1 or 2 as,
1) hvis n står for 1 har R' en annen betydning enn fluor, 1) if n stands for 1, R' has a different meaning than fluorine,
klor eller brom, og chlorine or bromine, and
2) hvis n står for 2 er begge R' like eller forskjellige og betyr en alkylgruppe med 1-5 karbonatomer, en alkoksygruppe me'd 1-<!>+ karbonatomer eller fluor, klor eller bro:n, 2) if n stands for 2, both R' are the same or different and mean an alkyl group with 1-5 carbon atoms, an alkoxy group with 1-<!>+ carbon atoms or fluorine, chlorine or bro:n,
R.j betyr en alkylgruppe med 1-5 karbonatomer, allyl-eller propargylgruppen, idet betydningen av alkylgruppe med 1-5 karbonatomer ikke medomfatter tert. alkylgrupper hvori det tert. karbonatom er bundet til ringnitrogenatomet, idet R' bare stå" for isopropylgruppen når n = 1 og R' beiyr cyan- eller acetamid-grupperi og Rp har den ovennevnte betydning, R.j means an alkyl group with 1-5 carbon atoms, the allyl or propargyl group, the meaning of alkyl group with 1-5 carbon atoms not including tert. alkyl groups in which the tert. carbon atom is bound to the ring nitrogen atom, with R' only standing for the isopropyl group when n = 1 and R' belonging to the cyano or acetamide group and Rp having the above meaning,
(1 ) omsettes forbindelser med den alminnelige formel III (1 ) compounds with the general formula III are reacted
hvori R', R.j , R 2 og n har den ovennevnte betydning, i nærvær av en katalytisk mengde Lewis-syre med et alkyl-karbonat, hvori alkylgruppen har 1-5 karbonatomer, eller (2) forbindelser med den alminnelige formel IV hvori R', R2 og n har den ovennevnte betydning og Me står for et alkalimetall, omsettes i et under reaksjonsbetingelsene inert organisk løsningsmiddel med forbindelser med den alminnelige formel V hvori R.<j> har den ovennevnte betydning og X står for klor, brom eller jod, eller b) for fremstilling av forbindelser med den alminnelige formel Ic hvori R^ og B.^ ^ar ^en ovennevnte betydning, og acetamido-derivater derav, reduseres forbindelser med den alminnelige formel Id hvori R^ og R^ har den ovennevnte betydning, overfores aminogruppen i forbindelser med den alminnelige formel Ih in which R', R.j , R 2 and n have the above meaning, in the presence of a catalytic amount of Lewis acid with an alkyl carbonate, in which the alkyl group has 1-5 carbon atoms, or (2) compounds of the general formula IV in which R ', R2 and n have the above meaning and Me stands for an alkali metal, is reacted in an organic solvent inert under the reaction conditions with compounds of the general formula V in which R.<j> has the above meaning and X stands for chlorine, bromine or iodine . , the amino group is transferred in compounds of the general formula Ih
hvori R^ og Rp har den ovennevnte betydning, i cyanogruppen etter Sandmeyer. in which R^ and Rp have the above meaning, in the cyano group according to Sandmeyer.
De to under avsnitt a) angitte fremgangsmåter for fremstilling The two manufacturing methods specified under section a).
av forbindelser med den alminnelige formel Ia kan gjennomføres, f. eks. som beskrevet i det følgende: of compounds with the general formula Ia can be carried out, e.g. as described in the following:
(1) Forbindelsene med den alminnelige formel III omsettes med alkylkarbamater, fortrinnsvis etylkarbamat, i nærvær av katalyt-tiske mengder av en Lewis-syre, f.eks. zinl&Lorid, ved temperaturer mellom 1<!>+0 og 230°C i 30 min. til 20 timer. Omsetningen kan g,jennorafores i nærvær av et under reaks jonsbetiingelsene inert organisk løsningsmiddel, f.eks. o-diklorbenzen, eller uten løsningsmiddel, idet i det siste tilfelle et overskudd av kar-bamat overtar funksjonen som løsningsmiddel. Etter avsluttet omsetning avkjøles reaksjonsblandingen til romtemperatur og behandles med an blanding bestående av et under reaksjonsbetingelsene inert organisk løsningsmiddel, f.eks. metylenklorid og vann. Etter fraskilling, tørring og inndamping av den organiske fase erholdes etter omkrystallisering de rene forbindelser med den alminnelige formel Ia. (2) Forbindelser med den alminnelige formel IV, fortrinnsvis deres natrium eller kaliumforbindelser, omsettes med forbindelser med den alminnelige formel V, fortrinnsvis deres jodider, i et under reaksjonsbetingelsene inert organisk løsningsmiddel, f.eks. dimetylacetamid, dietylacetamid, dimetylformamid, dimetylsulfoksyd eller dioksan. Omsetningen gjennomføres ved temperaturer mellom 20 og 100°C, idet omsetningen fortrinnsvis igangsettes ved romtemperatur i 1 - h timer og avsluttes ved koketemperaturen. Etter avsluttet omsetning inndampes reaksjonsblandingen og den herved erholdte rest blandes med is. Det dannede bunnfall frafiltreres og loses så i et under reaksjonsbetingelsene inert organisk løsningsmiddel, f.eks. i metylenklorid. Etter avdamping av løsningsmidlet og omkrystallisering erholdes de ønskede forbindelser med den alminnelige formel Ia i ren tilstand. (1) The compounds with the general formula III react with alkyl carbamates, preferably ethyl carbamate, in the presence of catalytic amounts of a Lewis acid, e.g. zinl&Lorid, at temperatures between 1<!>+0 and 230°C for 30 min. to 20 hours. The reaction can be carried out in the presence of an organic solvent inert under the reaction conditions, e.g. o-dichlorobenzene, or without solvent, in the latter case an excess of carbamate takes over the function as solvent. After completion of the reaction, the reaction mixture is cooled to room temperature and treated with a mixture consisting of an organic solvent inert under the reaction conditions, e.g. methylene chloride and water. After separation, drying and evaporation of the organic phase, the pure compounds with the general formula Ia are obtained after recrystallization. (2) Compounds of the general formula IV, preferably their sodium or potassium compounds, are reacted with compounds of the general formula V, preferably their iodides, in an organic solvent inert under the reaction conditions, e.g. dimethylacetamide, diethylacetamide, dimethylformamide, dimethylsulfoxide or dioxane. The reaction is carried out at temperatures between 20 and 100°C, with the reaction preferably being initiated at room temperature for 1 - h hours and ending at the boiling temperature. After completion of the reaction, the reaction mixture is evaporated and the resulting residue is mixed with ice. The formed precipitate is filtered off and then dissolved in an organic solvent that is inert under the reaction conditions, e.g. in methylene chloride. After evaporation of the solvent and recrystallization, the desired compounds with the general formula Ia are obtained in a pure state.
Hvis man tar sikte på fremstilling av forbindelser med den alminnelige formel Ia hvori ringnitrogenatomet i stilling 1 for chinazolinonringen er substituert med en forgrenet alkylgruppe, If one aims at producing compounds with the general formula Ia in which the ring nitrogen atom in position 1 of the quinazolinone ring is substituted with a branched alkyl group,
og forgreningen begynner på det karbonatom som er bundet til nitrogenatomet, f.eks. isopropyl eller sec. butyl, er det fordelaktig å benytte den under (1) beskrevne fremgangsmåte da denne fører til bedre utbytter. and the branching begins on the carbon atom that is bound to the nitrogen atom, e.g. isopropyl or sec. butyl, it is advantageous to use the method described under (1) as this leads to better yields.
Den under b) beskrevne fremgangsmåte for fremstilling av forbindelser med den alminnelige formel Ic kan gjennomføres som beskrevet i det følgende: The method described under b) for the preparation of compounds with the general formula Ic can be carried out as described in the following:
Forbindelser med den alminnelige formel Id løses hensiktsmessig Compounds with the general formula Id are resolved appropriately
i et under reaksjonsbetingelsene inert organisk løsningsmiddel, f.eks. etanol, og den erholdte løsning oppvarmes til koking. in an organic solvent inert under the reaction conditions, e.g. ethanol, and the resulting solution is heated to boiling.
Etter tilsetting av elementært metall, f.eks. jern (jernspon) tildryppes ved koketemperatur en mineralsyre, f.eks. saltsyre, Herved dannede forbindelser med den alminnelige formel Ic After addition of elemental metal, e.g. iron (iron filings) is dripped at boiling temperature with a mineral acid, e.g. hydrochloric acid, Hereby formed compounds with the general formula Ic
isoleres deretter på i og for seg kjent måte ved inndamping av is then isolated in a manner known per se by evaporation of
reaksjonsblandingen, oppløsning av resten i et under reaksjonsbetingelsene inert organisk løsningsmiddel, f.eks. etylacetat, the reaction mixture, dissolving the residue in an organic solvent inert under the reaction conditions, e.g. ethyl acetate,
sur ekstraksjon, alkalisk innstilling av ekstrakten, etc. og renses på i og for seg kjent måte, f.eks. ved omkrystallisering. De således erholdte forbindelser med den alminnelige formel Ic kan deretter eventuelt, hensiktsmessig løst i et egnet organisk løsningsmiddel, f.eks. pyridin, ved hjelp av behandling med egnede acetyleringsmidler, f.eks. eddiksyreanhydrid, overføres i de tilsvarende acetamidoderivater, som f.eks. kan isoleres ved inndamping av reaksjonsblandingen og renses ved omkrystallisering, f.eks. fra etylacetat. acid extraction, alkaline adjustment of the extract, etc. and purified in a manner known per se, e.g. by recrystallization. The thus obtained compounds with the general formula Ic can then optionally, appropriately, be dissolved in a suitable organic solvent, e.g. pyridine, by means of treatment with suitable acetylating agents, e.g. acetic anhydride, is transferred in the corresponding acetamido derivatives, which e.g. can be isolated by evaporation of the reaction mixture and purified by recrystallization, e.g. from ethyl acetate.
Den under avsnitt c) beskrevne fremgangsmåte for fremstilling The manufacturing method described under section c)
av forbindelser med den alminnelige formel le kan gjennomføres som bedrevet i det følgende: Forbindelser med den alminnelige formel If oppvarmes sammen med vandig bromhydrogensyre eller en løsning av hydrogenbromid i eddiksyre ved temperaturer mellom 60 ogHO°C, fortrinnsvis ved koketemperatur. Etter avsluttet omsetning innstilles reaksjonsblandingen ved tilsetning av et egnet alkalisk middel, f.eks. en vandig natriumhydroksydløsning, alkalisk og ekstraheres ved hjelp av et passende' under reaksjonsbetingelsene inert organisk løsningsmiddel, f.eks. etylacetat. De herved ekstraherte forbindelser med den alminnelige formel le isoleres deretter ved avdamping av løsningsmidlet og renses ved omkrystallisering. of compounds with the general formula le can be carried out as carried out in the following: Compounds with the general formula If are heated together with aqueous hydrobromic acid or a solution of hydrogen bromide in acetic acid at temperatures between 60 and HO°C, preferably at boiling temperature. After completion of the reaction, the reaction mixture is adjusted by adding a suitable alkaline agent, e.g. an aqueous sodium hydroxide solution, alkaline and extracted by means of a suitable organic solvent inert under the reaction conditions, e.g. ethyl acetate. The thus extracted compounds with the general formula 1e are then isolated by evaporation of the solvent and purified by recrystallization.
Den under avsnitt d) beskrevne fremgangsmåte for fremstilling av forbindelser med den alminnelige formel lg kan gjennomføres som beskrevet i det følgende: Forbindelser med den alminnelige formel Ih løses henholdsvis oppslemmes i et surt medium, f.eks. vandig saltsyre, og den således erholdte løsning henholdsvis oppslemning tilsettes en vandig løsning av alkalimetallnitrit, fortrinnsvis natriumnitrit-løsnirig. Den erholdte løsning av det tilsvarende diazoniumsalt tilsettes deretter en vandig løsning av et alkalimetallcyanid, fortrinnsvis natriumcyanid såvel som koppercyanid, og oppvarmes deretter ved en temperatur på 90 - 100°C. De erholdte forbindelser med den alminnelige formel lg isoleres deretter fra reaksjonsblandingen på i og for seg kjent måte, f.eks. ved ekstraksjon med et under reaksjonsbetingelsene inert organisk løsningsmiddel, f.eks. kloroform, og renses på i og for seg kjent måte, f.eks. ved kromatografering og omkrystallisering, f.eks. The method described under section d) for producing compounds with the general formula Ig can be carried out as described in the following: Compounds with the general formula Ih are dissolved or suspended in an acidic medium, e.g. aqueous hydrochloric acid, and the thus obtained solution or slurry is added to an aqueous solution of alkali metal nitrite, preferably sodium nitrite-solvent. The resulting solution of the corresponding diazonium salt is then added to an aqueous solution of an alkali metal cyanide, preferably sodium cyanide as well as copper cyanide, and then heated at a temperature of 90 - 100°C. The obtained compounds with the general formula Ig are then isolated from the reaction mixture in a manner known per se, e.g. by extraction with an organic solvent inert under the reaction conditions, e.g. chloroform, and purified in a manner known per se, e.g. by chromatography and recrystallization, e.g.
fra etanol/dietyleter. from ethanol/diethyl ether.
De ved fremgangsmåten 1) under avsnitt a) som utgangsforbindelser anvendte forbindelser med den alminnelige formel III er enten kjent eller kan fremstilles på i og for seg kjent måte. Hvis det skal fremstilles forbindelser med den alminnelige formel III som i 5-stillingen er substituert med en nitro-eller trifluor-metylgruppe, anbefales det å omsette et tilsvarende 5-(nitro-eller trifluormetyl )-2-klor-benzofenon med et egnet amin (R-jOT^ hvori R.J ' har den ovennevnte betydning) i nærvær av en egnet katalysator, f.eks. en blanding av kopper og kopperklorid. Hvis det skal fremstilles forbindelser med den alminnelige formel III, hvori aminogruppen er substituert med en forgrenet alkylrest, hvor forgreningen går ut fra det karbonatom som er bundet til nitrogenatomet, særlig med isopropylresten, er det gunstig å anvende en omsetning mellom tilsvarende o-aminobenzofenon og et sec. alkylbromid eller jodid. The compounds of the general formula III used as starting compounds in method 1) under section a) are either known or can be prepared in a manner known per se. If compounds with the general formula III are to be prepared which are substituted in the 5-position with a nitro- or trifluoromethyl group, it is recommended to react a corresponding 5-(nitro- or trifluoromethyl)-2-chloro-benzophenone with a suitable amine (R-jOT^ wherein R.J' has the above meaning) in the presence of a suitable catalyst, e.g. a mixture of copper and copper chloride. If compounds with the general formula III are to be prepared, in which the amino group is substituted with a branched alkyl residue, where the branching starts from the carbon atom that is bound to the nitrogen atom, in particular with the isopropyl residue, it is advantageous to use a reaction between the corresponding o-aminobenzophenone and a second alkyl bromide or iodide.
De ved fremgangsmåte 2) under avsnitt a) som utgangsforbindelser anvendte forbindelser med den alminnelige formel IV kan fremstilles ved at tilsvarende 1-stillingen usubstituerte chinazolin-oner omsettes med alkalimetallforbindelser, f.eks. natriumhydrid eller med et alkalimetalloksyd som f.eks. natriummetoksyd, natriumotoksyd, kaliummetoksyd eller kalium-atoksyd, i et under reaksjonsbetingelsene inert organisk løsningsmiddel, f.eks. dimetylacetamid, dietylacetamid, dimetylformamid, dimetylsulfoksyd eller dioksan, ved romtemperatur. Med fordel anvendes for denne omsetning et under reaksjonsbetingelsene inert organisk løsnings-middel, som deretter også kan anvendes for fremstilling av forbindelser med den alminnelige formel Ia. The compounds of the general formula IV used as starting compounds in method 2) under section a) can be prepared by reacting unsubstituted quinazolinones corresponding to the 1-position with alkali metal compounds, e.g. sodium hydride or with an alkali metal oxide such as e.g. sodium methoxide, sodium ethoxide, potassium methoxide or potassium ethoxide, in an organic solvent inert under the reaction conditions, e.g. dimethylacetamide, diethylacetamide, dimethylformamide, dimethylsulfoxide or dioxane, at room temperature. An organic solvent which is inert under the reaction conditions is advantageously used for this reaction, which can then also be used for the preparation of compounds with the general formula Ia.
De for den ovennevnte fremgangsmåte som utgangsforbindelser anvendte, i 1-stillingen usubstituerte cliinazolinoner er enten kjent (japansk patentskrift 20 865/65)eller kan fremstilles på i og for seg kjent måte fra kjente utgangsforbindelser. F.eks. kan for dette tilsvarende substituerte 2-amino-benzofenoner etter fremgangsmåten 1) under avsnitt a) underkastes en ringslutnings-reaks jon. The cliinazolinones unsubstituted in the 1-position used as starting compounds for the above-mentioned process are either known (Japanese patent document 20 865/65) or can be prepared in a manner known per se from known starting compounds. E.g. for this, correspondingly substituted 2-amino-benzophenones can be subjected to a cyclization reaction according to method 1) under section a).
De under avsnittene b) henholdsvis c) som utgangsforbindelser anvendte forbindelser med den alminnelige formel Id henholdsvis If kan fremstilles fra tilsvarende utgangsforbindelser under anvendelse av de i avsnitt a) henholdsvis e) beskrevne fremgangsmåter, idet det må påsees at fremgangsmåten 1) avsnitt a) særlig er egnet for fremstilling av i 1-stillingen med forgrenede alkylgruppe r (sec. alkylgrupper) substituerte sluttforbindelser, og at fremgangsmåten under avsnitt e) særlig er egnet for fremstilling av i 1-stillingen med tert. alkylgrupper substituerte sluttforbindelser. The compounds with the general formula Id and If used as starting compounds under sections b) and c) respectively can be prepared from corresponding starting compounds using the methods described in sections a) and e) respectively, as it must be ensured that the method 1) section a) in particular is suitable for the preparation of final compounds substituted in the 1-position with branched alkyl groups r (sec. alkyl groups), and that the method under section e) is particularly suitable for the preparation of in the 1-position with tert. alkyl groups substituted end compounds.
De under avsnitt d) som utgangsforbindelser anvendte forbindelser mad den alminnelige formel Ih kan fremstilles fra tilsvarende utgangsforbindelser etter fremgangsmåten i avsnitt b). The compounds of the general formula Ih used as starting compounds under section d) can be prepared from corresponding starting compounds according to the procedure in section b).
De ved fremgangsmåten i henhold til oppfinnelsen erholdbare forbindelser med den alminnelige formel I besitter overorgentlig gunstige farmakodynamiske egenskaper. Særlig har disse forbindelser, hvilket kan sluttes fra resultatene ved Carragen-indusert Odem-test ved rotter, en gunstig betennelseshindrende virkning. Den daglig administrerbare dose skal utgjore mellom 10 og 1000 mg, som fortrinnsvis tilfores i flere (2-^) daglige doser på 3~500 mg eller i retardert form. Forbindelsene med den alminnelige formel I besitter utover dette analgetisk, antipyretisk og antibradykinin-virkning. De for den analgetiske eller antipyretiske anvendelse nødvendige doser tilsvarer de som kreves for den betennelseshemmende anvendelse. The compounds of the general formula I obtainable by the method according to the invention possess extremely favorable pharmacodynamic properties. In particular, these compounds, which can be concluded from the results of the Carrageen-induced Oedema test in rats, have a beneficial anti-inflammatory effect. The daily administrable dose should be between 10 and 1000 mg, which is preferably administered in several (2-^) daily doses of 3~500 mg or in delayed form. The compounds of the general formula I also possess analgesic, antipyretic and antibradykinin action. The doses required for the analgesic or antipyretic use correspond to those required for the anti-inflammatory use.
For anvendelsen som betennelseshemmende middel har på grunnlag For its use as an anti-inflammatory agent
av de ovennevnte prover de forbindelser med den alminnelige formel I vist seg spesielt brukbare, hvori R^ betyr metyl, etyl, isopropyl, tert. butyl, allyl eller propargyl, fortrinnsvis dog etyl, isopropyl og tert. butyl særlig da isopropyl, og R2 betyr of the above, the compounds with the general formula I prove to be particularly useful, in which R 1 means methyl, ethyl, isopropyl, tert. butyl, allyl or propargyl, preferably, however, ethyl, isopropyl and tert. butyl especially as isopropyl, and R 2 means
en usubstituert fenylgruppe. Hvis R, Y eller Y^ står for -en alkylgruppe, skal disse fortrinnsvis inneholde 1-3 karbonatomer og, hvis R, Y eller Y1 står for en alkoksygruppe skal disse fortrinnsvis inneholde 1 eller 2 karbonatomer, Hvis R står for en alkyltiogruppe bor denne fortrinnsvis inneholde 1 eller 2 karbonatomer. an unsubstituted phenyl group. If R, Y or Y^ represents an alkyl group, these should preferably contain 1-3 carbon atoms and, if R, Y or Y1 represents an alkoxy group, these should preferably contain 1 or 2 carbon atoms. If R represents an alkylthio group, this preferably contain 1 or 2 carbon atoms.
En gunstig virkning har imidlertid også forbindelser hvori n står for 2. Forbindelser, hvori n står for 1 og R betyr en alkylgruppe, en alkoksygruppe, en tioalkylgruppe eller trifluormetyl-gruppen, såvel som hvori R betyr hydroksygruppen, aminogruppen, cyanogruppen, nitrogruppen (særlig når R^ står for den teit. butyl-gruppe), acetamidogruppen eller merkaptogruppen. However, compounds in which n stands for 2 also have a beneficial effect. Compounds in which n stands for 1 and R means an alkyl group, an alkoxy group, a thioalkyl group or the trifluoromethyl group, as well as in which R means the hydroxy group, the amino group, the cyano group, the nitro group (especially when R 1 stands for the tert. butyl group), the acetamido group or the mercapto group.
De ved fremgangsmåten i henhold til oppfinnelsen fremstillbare forbindelser eller deres salter kan anvendes som legemiddel i seg selv eller i tilsvarende preparatformer for oral eller paren-teral tilførsel. For fremstilling av egnede preparatformer for-arbeides forbindelsene med uorganiske eller organiske, farmako-logisk indifferente hjelpestoffer. The compounds or their salts which can be prepared by the method according to the invention can be used as medicine in themselves or in corresponding preparation forms for oral or parenteral administration. For the production of suitable preparation forms, the compounds are prepared with inorganic or organic, pharmacologically indifferent excipients.
Som hjelpestoffer anvendes f.eks.: Excipients are used, for example:
for tabletter og drageer anvendes således melkesukker, stivelse, for tablets and dragees, therefore, milk sugar, starch,
talkum, stearinsyre etc., talc, stearic acid etc.,
for siruper anvendes f.eks. rorsukker-, invertsukker-, glukose-losninger etc., for syrups, e.g. cane sugar, invert sugar, glucose solutions etc.,
for injeksjonspreparater anvendes f.eks. vann, alkoholer, for injection preparations are used e.g. water, alcohols,
glycerol, planteoljer og lignende. glycerol, vegetable oils and the like.
Videre kan preparatene inneholde egnede konserverings-, stabiliserings-, fukte-midler, losningsformidlere, stotnings- og fargestoffer, aromabestanddeler etc. Furthermore, the preparations may contain suitable preservatives, stabilisers, wetting agents, release agents, thickeners and colourants, aroma components etc.
I de etterfølgende eksempler, som skal illustrere utførelsen av fremgangsmåten samt fremstilling av de anvendte utgangsforbindelser, er alle temperaturangivelser i °C og er korrigert. In the following examples, which shall illustrate the execution of the method and the preparation of the starting compounds used, all temperature indications are in °C and have been corrected.
Eksempel 1: 6, 7- dimetyl- l- etyl-^- feny1- 2( 1H)- chinazolinon Example 1: 6,7-Dimethyl-1-ethyl-^-phenyl-2(1H)-quinazolinone
a) §iZl^i5<®>t<y>il^ll!22<y>Il2(1H)-ch<ln>azolinon a) §iZl^i5<®>t<y>il^ll!22<y>Il2(1H)-ch<ln>azolinone
En blanding av 10 g <1>+,5-dimetyl-2-aminobenzofenon, 20 g uretan A mixture of 10 g <1>+,5-dimethyl-2-aminobenzophenone, 20 g urethane
og 2 g sinkklorid holdes i 2 timer ved 180 - 200°C (oljebadtemperatur) avkjoles deretter til romtemperatur og tilsettes 100 ml av en blanding av metylenklorid/vann (1:). Den organiske fase fraskilles, torres over vannfritt natriumsulfat, filtreres og losningsmidlet avdampes. Etter omkrystallisering av. resten fra etylacetat erholdes 6 ,7-dimetyl-l+-f enyl-2 (1H)-chinazolinon som beige-fargede krystaller. Smeltepunktet ligger over 280°C. and 2 g of zinc chloride are held for 2 hours at 180 - 200°C (oil bath temperature), then cooled to room temperature and 100 ml of a mixture of methylene chloride/water (1:) is added. The organic phase is separated, dried over anhydrous sodium sulphate, filtered and the solvent evaporated. After recrystallization of. the residue from ethyl acetate, 6,7-dimethyl-1+-phenyl-2(1H)-quinazolinone is obtained as beige-coloured crystals. The melting point is above 280°C.
<b>) §aZl^i52i2ililf:iZil^l£§5<y>.il<2>(<1>^ <b>) §aZl^i52i2ililf:iZil^l£§5<y>.il<2>(<1>^
1 g natriumhydrid ( 50% suspensjon i mineralolje) tilsettes 1 g of sodium hydride (50% suspension in mineral oil) is added
ved romtemperatur en losning av K£ g 6,7-dimetyl-*+-f enyl-2(1H)-chinazolinon i 100 ml dietylacetamid. Den erholdte blanding, som inneholder natriumforbindelsen av 6,7-dimetyl-l+-fenyl-2(1H)-chinazolinon, rores i 15 min. ved romtemperatur og tilsettes deretter 10 ml etyljodid. Deretter rores i 30 min. ved romtemperatur og for å gjore omsetningen fullstendig oppvarmes i 30 min. ved 6o°C. Blandingen'inndampes i vakuum hvorved losningsmidlet stort sett fjernes, og resten blandes med 100 g is. Deretter frafUtreres, resten loses i 50 ml metylenklorid og den erholdte losning torres over natriumsulfat. Etter inndamping i vakuum og omkrystallisering av den oljeaktige rest fra etanol/dietyleter (1 :1) erholdes 6 ,7-dimetyl-1-etyl-l+-fenyl-2(1H)-chinazolinon med smeltepunkt 176-180°C. at room temperature a solution of K£ g 6,7-dimethyl-*+-phenyl-2(1H)-quinazolinone in 100 ml of diethylacetamide. The resulting mixture, which contains the sodium compound of 6,7-dimethyl-1+-phenyl-2(1H)-quinazolinone, is stirred for 15 minutes. at room temperature and then add 10 ml of ethyl iodide. Then stir for 30 min. at room temperature and to make the turnover complete is heated for 30 min. at 6o°C. The mixture is evaporated in a vacuum whereby the solvent is mostly removed, and the residue is mixed with 100 g of ice. It is then filtered off, the residue is dissolved in 50 ml of methylene chloride and the resulting solution is dried over sodium sulphate. After evaporation in vacuum and recrystallization of the oily residue from ethanol/diethyl ether (1:1), 6,7-dimethyl-1-ethyl-1+-phenyl-2(1H)-quinazolinone with a melting point of 176-180°C is obtained.
Eksempel 2:' ^ f- fenyl- 1, 6, 7- trimetyl~ 2( 1H)- chihazolinon Example 2:' ^f-phenyl-1,6,7-trimethyl~ 2(1H)-chihazolinone
0,75 g natriumhydrid (50$ suspensjon i mineralolje) tilsettes 0.75 g of sodium hydride (50% suspension in mineral oil) is added
ved romtemperatur en losning av <*>+,5 g 6,7-dimetyl-^-f enyl-2(1H)-chinazolinon (fremstilt... etter<->den i eksempel. 1a) beskrevene fremgangsmåte) i 100 ml dimetylformamid. Den erholdte . blanding som inneholder natriumforbindelsen av 6,7-dimetyl-^t—f enyl-2(1 H)-chinazolinon, rores i 15 min. og tilsettes deretter *f ml metyljodid. Deretter rores i 30 min. at room temperature a solution of <*>+.5 g of 6,7-dimethyl-^-phenyl-2(1H)-quinazolinone (prepared... according to<->the method described in example. 1a) in 100 ml dimethylformamide. It obtained . mixture containing the sodium compound of 6,7-dimethyl-[t-phenyl-2(1H)-quinazolinone, is stirred for 15 min. and then *f ml of methyl iodide is added. Then stir for 30 min.
ved romtemperatur, for vidtgående fjernelse av losningsmidlet inndampes i vakuum og resten blandes med 100 ,g is. Det utfelte bunnfall frafiltreres, loses i 50 ml metylenklorid, den erholdte losning torres over natriumsulfat og losningsmidlet inndampes i vakuum. Etter omkrystallisering fra dietyl- at room temperature, for extensive removal of the solvent is evaporated in vacuum and the residue is mixed with 100 g of ice. The precipitate that precipitates is filtered off, dissolved in 50 ml of methylene chloride, the solution obtained is dried over sodium sulphate and the solvent is evaporated in vacuo. After recrystallization from diethyl
eter erholdes ^--fenyl-1,6,7-trimetyl-2(1H)-chinazolinon som hvite krystaller med smeltepunkt 20If-206oC. ether, ^--phenyl-1,6,7-trimethyl-2(1H)-quinazolinone is obtained as white crystals with a melting point of 20If-206oC.
Eksempel 3; 6 ^-dimetyl-^-fenyl-1-propargyl-2(1H)-chinazolinon Example 3; 6 ^-Dimethyl-^-phenyl-1-propargyl-2(1H)-quinazolinone
0,75 g natriumhydid ( 50% suspensjon i mineralolje) tilsettes ved romtemperatur en losning av ^,5 g 6,7-dimetyl-1+-f enyl-2(1H)-chinazolinon i 100 ml dimetylformamid. Den erholdte blanding, som inneholder natriumforbindelsen av 6,7-dimetyl-<l>+-fenyl-2(1H)-chinazolinon, rores i 15 min. ved romtemperatur og tilsettes deretter <*>f ml propargylbromid. Deretter rores i 30 min. ved romtemperatur, inndampes for vidtgående fjerning av losningsmidlet i vakuum og resten blandes med 100 g is. 0.75 g of sodium hydride (50% suspension in mineral oil) is added at room temperature to a solution of .5 g of 6,7-dimethyl-1+-phenyl-2(1H)-quinazolinone in 100 ml of dimethylformamide. The resulting mixture, which contains the sodium compound of 6,7-dimethyl-<1>+-phenyl-2(1H)-quinazolinone, is stirred for 15 min. at room temperature and then <*>f ml of propargyl bromide is added. Then stir for 30 min. at room temperature, is evaporated to remove the solvent extensively in vacuum and the residue is mixed with 100 g of ice.
Det utfallende bunnfall frafiltreres, loses i 50 ml metylen-klorid, den erholdte losning torres over natriumsulfat og losningsmidlet inndampes i vakuum. Etter omkrystallisering fra dietyleter erholdes 6,7-dimetyl-^-fenyl-1-propargyl-2(1H)-chinazolinon som hvite krystaller med smeltepunkt fra 202-205°C The resulting precipitate is filtered off, dissolved in 50 ml of methylene chloride, the solution obtained is dried over sodium sulphate and the solvent is evaporated in vacuo. After recrystallization from diethyl ether, 6,7-dimethyl-^-phenyl-1-propargyl-2(1H)-quinazolinone is obtained as white crystals with a melting point of 202-205°C
Eksempel h: 1 -etyl-^f-f enyl-6-trifluormetyl-2(1H)-chinazolinon Example h: 1-ethyl-[f-phenyl-6-trifluoromethyl-2(1H)-quinazolinone
a) 5-trifluormetyl-2-etylaminobenzofenon a) 5-trifluoromethyl-2-ethylaminobenzophenone
En blanding av 10 g 5-trifluormetyl-2-klorbenzofenon, 500 A mixture of 10 g of 5-trifluoromethyl-2-chlorobenzophenone, 500
mg kopperpulver, 500 mg kopperklorid og 100 ml flytende- etylamin oppvarmes i 2 timer i autoklav ved 130 - 1<1>+0°C. Deretter helles reaksjonsblandingen ut i 200 ml etylacetat og ekstraheres 2 ganger med vann. Den organiske fase fraskilles, torres over vannfritt natriumsulfat, filtreres og inndampes til tbrrhet i vakuum. Resten oppvarmes i 20 ml dioksan og 30 ml 6N saltsyre, den erholdte losning innstilles alkalisk med natriumhydroksyd og ekstraheres 2 ganger med 100 ml etylacetat. De forente organiske faser torres over vannfritt natriumsulfat og inndampes til torrhet i vakuum. Etter omkrystallisering av resten fra etanol erholdes 5-trifluormetyl-2-etyl-aminobeno-fenon som gule prismer med smeltepunkt 78-80°C. mg copper powder, 500 mg copper chloride and 100 ml liquid ethylamine are heated for 2 hours in an autoclave at 130 - 1<1>+0°C. The reaction mixture is then poured into 200 ml of ethyl acetate and extracted twice with water. The organic phase is separated, dried over anhydrous sodium sulphate, filtered and evaporated to dryness in vacuo. The residue is heated in 20 ml of dioxane and 30 ml of 6N hydrochloric acid, the resulting solution is made alkaline with sodium hydroxide and extracted twice with 100 ml of ethyl acetate. The combined organic phases are dried over anhydrous sodium sulfate and evaporated to dryness in vacuo. After recrystallization of the residue from ethanol, 5-trifluoromethyl-2-ethylaminobenophenone is obtained as yellow prisms with a melting point of 78-80°C.
b) 1-ety.il1*-^ eny_l-6-trif luormety_l-2 (1_H) -chinazolinon b) 1-Ethy.yl1*-^enyl-1-6-trifluoromethyl-1-2 (1_H)-quinazolinone
En blanding av 6,5 g 5-trifluormetyl-2-etylaminobenzofenon, A mixture of 6.5 g of 5-trifluoromethyl-2-ethylaminobenzophenone,
2 g uretan og 20 mg zinkklorid holdes i 20 timer ved l<!>+0- 2 g of urethane and 20 mg of zinc chloride are kept for 20 hours at l<!>+0-
150aC (oljebadtemperatur), deretter avkjoles til romtemperatur og tilsettes 100 ml av en blanding av metylenklorid/ 150aC (oil bath temperature), then cool to room temperature and add 100 ml of a mixture of methylene chloride/
vann (1:). Den organiske fase fraskilles, torres over vannfritt natriumsulfat, filtreres og losningsmidlet avdampes. Etter omkrystallisering av resten fra dietyleter erholdes 1-etyl-V-fenyl-6-trifluormetyl-2(1H)-chinazolinon som gule prismer som sublimerer ved 180°C. water (1:). The organic phase is separated, dried over anhydrous sodium sulphate, filtered and the solvent evaporated. After recrystallization of the residue from diethyl ether, 1-ethyl-V-phenyl-6-trifluoromethyl-2(1H)-quinazolinone is obtained as yellow prisms which sublime at 180°C.
Eksempel 5: 1 - etyl- 6- nitro- 1+- fenyl- 2( 1H)- chinazolinon Example 5: 1-ethyl-6-nitro-1+-phenyl-2(1H)-quinazolinone
a) 5-nitro-2-etylaminobenzofenon a) 5-nitro-2-ethylaminobenzophenone
En blanding av 15 g 5-nitro-2-klorbenzofenon, 700 mg kopperpulver, 700 mg kopperklorid, 15 ml etanol og 15 ml flytende etylamin oppvarmes i 7 timer til koking under tilbakelop. Det herved erholdte krystalline material frafiltreres, loses i 200 ml metylenklorid, behandles med trekull og , filtreres. Filtratet inndampes til torrhet i vakuum og resten omkrystalliseres fra etanol, idet 5~ni"tro-2-etyl-aminobenzofenon erholdes som gule prismer med smeltepunkt 132-133°C. A mixture of 15 g of 5-nitro-2-chlorobenzophenone, 700 mg of copper powder, 700 mg of copper chloride, 15 ml of ethanol and 15 ml of liquid ethylamine is heated to reflux for 7 hours. The crystalline material thus obtained is filtered off, dissolved in 200 ml of methylene chloride, treated with charcoal and filtered. The filtrate is evaporated to dryness in vacuo and the residue is recrystallized from ethanol, 5-nitro-2-ethyl-aminobenzophenone being obtained as yellow prisms with a melting point of 132-133°C.
b) 1-etyl-6-nitro-^-fenyl-2(1H)-chinazolinon b) 1-ethyl-6-nitro-^-phenyl-2(1H)-quinazolinone
En blanding av 37 g 5-nitro-2-etylaminobenzofenon, ho g uretan A mixture of 37 g of 5-nitro-2-ethylaminobenzophenone, high urethane
og 1,5 g zinkklorid holdes i h timer ved 180-200°C (oljebadtemperatur), avkjoles deretter til romtemperatur og tilsettes 200 ml metylenklorid. Den erholdte blanding filtreres og filtratet ekstraheres 2 ganger med hver gang 100 ml vann. Den organiske fase torres over vannfritt natriumsulfat og inndampes i vakuum. Etter omkrystallisering av resten fra metanol erholdes 1-etyl-6-nitro-1+-fenyl-2(1H)-chinazolinon i form av gule prismer med smeltepunkt 21^-215°C. and 1.5 g of zinc chloride are held for h hours at 180-200°C (oil bath temperature), then cooled to room temperature and 200 ml of methylene chloride are added. The resulting mixture is filtered and the filtrate is extracted twice with 100 ml of water each time. The organic phase is dried over anhydrous sodium sulfate and evaporated in vacuo. After recrystallization of the residue from methanol, 1-ethyl-6-nitro-1+-phenyl-2(1H)-quinazolinone is obtained in the form of yellow prisms with a melting point of 21^-215°C.
Eksempel 6: 6-amino-1 -isopropyl->+-fenyl-2(1H)-chinazolinon Example 6: 6-amino-1-isopropyl->+-phenyl-2(1H)-quinazolinone
a) 5l2it£o=2-isogrcp_y_laminobenzof 2322 a) 5l2it£o=2-isogrcp_y_laminobenzof 2322
En blanding av 15 g 5-nitro-2-klorbenzofenon, 700 mg kopperpulver, 700 mg kopperklorid, 15 ml etanol og 15 ml flytende isopropylamin oppvarmes i 20 timer til koking under tilbakelop. Det herved erholdte krystalline material frafiltreres, loses i 200 ml metylen-klorid, behandles med trekull og filtreres. Filtratet inndampes til torrhet i vakuum og resten omkrystalliseres fra etanol, idet 5-nitro-2-isopropyl-aminobenzofenon erholdes i form av gule prismer med smeltepunkt 155°C A mixture of 15 g of 5-nitro-2-chlorobenzophenone, 700 mg of copper powder, 700 mg of copper chloride, 15 ml of ethanol and 15 ml of liquid isopropylamine is heated to reflux for 20 hours. The crystalline material thus obtained is filtered off, dissolved in 200 ml of methylene chloride, treated with charcoal and filtered. The filtrate is evaporated to dryness in vacuo and the residue is recrystallized from ethanol, 5-nitro-2-isopropyl-aminobenzophenone being obtained in the form of yellow prisms with a melting point of 155°C
<k>) §lSit£°zlzi22EE2E^Il'±z£§^il2 (1 H)-chinazolinon <k>) §lSit£°zlzi22EE2E^Il'±z£§^il2 (1 H)-quinazolinone
En blanding. av 37 g 5-nitro-2-isopropylaminobenzofenon, k- 0 g uretan og 1,5 g zinkklorid holdes i k timer ved 180-200°C (oljebadtemperatur), avkjoles deretter til romtemperatur og tilsettes 200 ml metylenklorid. Den erholdte blanding filtreres og filtratet ekstraheres 2 ganger med hver gang 100 ml vann. Den organiske fase torres over vannfritt natriumsulfat og inndampes i vakuum. Etter omkrystallisering av resten fra etylacetat erholdes 6-nitro-1 -isopropyl-^f-feny.1-2(1H)-chinazolinon i form av gule prismer med smeltepunkt 190-192°C. A mixture. of 37 g of 5-nitro-2-isopropylaminobenzophenone, k-0 g of urethane and 1.5 g of zinc chloride are kept for k hours at 180-200°C (oil bath temperature), then cooled to room temperature and 200 ml of methylene chloride are added. The resulting mixture is filtered and the filtrate is extracted twice with 100 ml of water each time. The organic phase is dried over anhydrous sodium sulfate and evaporated in vacuo. After recrystallization of the residue from ethyl acetate, 6-nitro-1-isopropyl-3-phenyl-1-2(1H)-quinazolinone is obtained in the form of yellow prisms with a melting point of 190-192°C.
c) §-amino^=iso£r^<p>y_l-^-f^n^c) §-amino^=iso£r^<p>y_l-^-f^n^
En blanding av 1 2 g 6-nitro-1 -isopropyl-^-fenyl-2'(1H)-chinazolinon A mixture of 1 2 g of 6-nitro-1-isopropyl-^-phenyl-2'(1H)-quinazolinone
lost i 2^0 ml varm etanol, oppvarmes til koking og tilsettes under roring forst 80 ml vann og deretter 16 g jernspon. Deretter tilsettes dråpevis under roring en losning fremstilt av 80 ml etanol, 20 ml vann og k- ml 2N saltsyre, i lopet av ^0 min. Den erholdte blanding oppvarmes i 3 timer under tilbakelop, den dissolved in 2^0 ml of hot ethanol, heated to boiling and, while stirring, first 80 ml of water and then 16 g of iron filings are added. A solution prepared from 80 ml of ethanol, 20 ml of water and 100 ml of 2N hydrochloric acid is then added dropwise with stirring over the course of 10 min. The resulting mixture is heated for 3 hours under reflux
varme losning tilsettes k- ml av en vandig 2N natriumhydroksydlosning, filtreres og inndampes for vidtgående fjernelse av etanol i vakuum. Etter tilsetting av 100 ml etylacetat ekstraheres den organiske fase 3 ganger med hver gang 50 ml fortynnet saltsyre. De forente vandige faser innstilles alkalisk med vandig natriumhydroksydlosning og ekstraheres 2 ganger med hver gang 100 ml metylenklorid.- De organiske faser forenes, torres: over vannfritt natriumsulfat, filtreres og inndampes til torrhet i vakuum. Etter omkrystallisering av resten fra etylacetat erholdes 6-amino-1-isopropyl-if-fenyl-2(1H)-chinazolinon i form av gule prismer med smeltepunkt 210-215°C. warm solution, k-ml of an aqueous 2N sodium hydroxide solution is added, filtered and evaporated for extensive removal of ethanol in vacuum. After adding 100 ml of ethyl acetate, the organic phase is extracted 3 times with 50 ml of dilute hydrochloric acid each time. The combined aqueous phases are made alkaline with aqueous sodium hydroxide solution and extracted twice with 100 ml of methylene chloride each time.- The organic phases are combined, dried: over anhydrous sodium sulfate, filtered and evaporated to dryness in vacuo. After recrystallization of the residue from ethyl acetate, 6-amino-1-isopropyl-if-phenyl-2(1H)-quinazolinone is obtained in the form of yellow prisms with a melting point of 210-215°C.
Eksempel 7: 6-acetamido-1 -isopropyl-^f-fenyl-2(1 H)-22i2§3°iin2S Example 7: 6-acetamido-1-isopropyl-β-phenyl-2(1H)-22i2§3°iin2S
En losning av 2,65 g 6-amino-1-isopropyl-^--fenyl-2(1H)-chinazolinon (fremstilt etter den i eksempel' 6 beskrevne fremgangsmåte) i 25 ml pyridin og 25 ml eddiksyreanhydrid, oppvarmes i 3jr time ved 70°C. Den erholdte klare losning inndampes til torrhet i vakuum og resten omkrystalliseres fra etylacetat, idet 6-acetamido-1-isopropyl-^-fenyl-2(1H)-chinazolinon erholdes i A solution of 2.65 g of 6-amino-1-isopropyl-^--phenyl-2(1H)-quinazolinone (prepared according to the method described in Example 6) in 25 ml of pyridine and 25 ml of acetic anhydride is heated for 3 hours at 70°C. The clear solution obtained is evaporated to dryness in vacuo and the residue is recrystallized from ethyl acetate, 6-acetamido-1-isopropyl-^-phenyl-2(1H)-quinazolinone being obtained in
form av gule prismer med smeltepunkt 278-280°C. form of yellow prisms with melting point 278-280°C.
Eksempel 8: 6- cyano- 1 - isopropyl-^ f- fenyl- 2( 1H)- chinazolinon Example 8: 6-cyano-1-isopropyl-^f-phenyl-2(1H)-quinazolinone
En blanding av M-,2 g 6-amino-1-isopropyl-^-fenyl-2(1 H)-chinazolinon (fremstilt etter den i eksempel 6 beskrevne fremgangsmåte) og fortynnet saltsyre diazoteres ved en temperatur på 0-5°C med 15 ml av en vandig 1N natriumnitrit-losning. Den erholdte losning tilsettes uten opphold (i lopet av 5 min) til en losning av 12 g natriumcyanid og 22 g koppercyanid i 500 ml vann ved romtemperatur og oppvarmes deretter i <*>+5 min. ved en temperatur på 90-100°C (vannbad). Den erholdte blanding avkjoles til romtemperatur, tilsettes 200 ml kloroform og uopplost material frafiltreres. Den organiske fase fraskilles og ekstraheres en gang med 100 ml 1N saltsyre og en gang med 50 ml fortynnet vandig natriumbikarbonatlosning. Den organiske fase torres over vannfritt natriumsulfat, filtreres og inndampes til torrhet i vakuum. Det rå reaksjonsprodukt loses i metylenklorid og renses ved filtrering over en kort kolonne med aluminiumoksyd. Filtratet omkrystalliseres etter fjernelse av losningsmidlet fra etanol/ dietyleter (1 :1 ). A mixture of M-.2 g of 6-amino-1-isopropyl-^-phenyl-2(1 H)-quinazolinone (prepared according to the method described in example 6) and dilute hydrochloric acid is diazotized at a temperature of 0-5°C with 15 ml of an aqueous 1N sodium nitrite solution. The obtained solution is added without delay (in the course of 5 min) to a solution of 12 g of sodium cyanide and 22 g of copper cyanide in 500 ml of water at room temperature and is then heated for <*>+5 min. at a temperature of 90-100°C (water bath). The resulting mixture is cooled to room temperature, 200 ml of chloroform is added and undissolved material is filtered off. The organic phase is separated and extracted once with 100 ml of 1N hydrochloric acid and once with 50 ml of dilute aqueous sodium bicarbonate solution. The organic phase is dried over anhydrous sodium sulfate, filtered and evaporated to dryness in vacuo. The crude reaction product is dissolved in methylene chloride and purified by filtration over a short column of aluminum oxide. The filtrate is recrystallized after removing the solvent from ethanol/diethyl ether (1:1).
Herved erholdes 6-cyano-1-isopropyl-^-fenyl-2(1H)-chinazolinon This gives 6-cyano-1-isopropyl-3-phenyl-2(1H)-quinazolinone
i form av krystalline prismer med smeltepunkt 125-128°C. in the form of crystalline prisms with a melting point of 125-128°C.
Eksempel 9: 1 - etyl- 6- metyl-^ f- fenyl- 2( 1H)- chinazolinon Example 9: 1-ethyl-6-methyl-^f-phenyl-2(1H)-quinazolinone
a) 6-metyl-^--f enyl-2(^H)-chinazolinon a) 6-Methyl-^--phenyl-2(^H)-quinazolinone
En blanding av 5 g 5-metyl-2-aminobenzofenon og h g urinstoff A mixture of 5 g of 5-methyl-2-aminobenzophenone and 1 g of urea
oppvarmes i 2 timer ved en temperatur på 180-200°C. Den faste rest behandles med 100 ml av en 50% vandig etanollosning og filtreres, idet 6-metyl-<l>+-fenyl-2(1H)-chinazolinon erholdes som krystalline beige fargede krystaller med smeltepunkt 280-281°C. heated for 2 hours at a temperature of 180-200°C. The solid residue is treated with 100 ml of a 50% aqueous ethanol solution and filtered, whereby 6-methyl-<1>+-phenyl-2(1H)-quinazolinone is obtained as crystalline beige colored crystals with a melting point of 280-281°C.
il§tXil§z5§^iz^ll!§52iliI15}l22i2§ZOiinon il§tXil§z5§^iz^ll!§52iliI15}l22i2§ZOiinon
Analogt den i eksempel 1 beskrevne fremgangsmåte erholdes ved erstatning av det deri anvendte 6,7-dimetyl-W-fenyl-2(1H)-chinazolinon med en ekvivalent mengde 6-metyl-^-fenyl-2(1H)-chinazolinon og omkrystallisering av resten fra etyleter den .onskede forbindelse 1-etyl-6-metyl-^-fenyl-2(1H)-chinazolinon i form av gule nåler med smeltepunkt 180°C. Analogously to the method described in example 1, it is obtained by replacing the 6,7-dimethyl-N-phenyl-2(1H)-quinazolinone used therein with an equivalent amount of 6-methyl-^-phenyl-2(1H)-quinazolinone and recrystallization of the residue from ethyl ether the desired compound 1-ethyl-6-methyl-^-phenyl-2(1H)-quinazolinone in the form of yellow needles with melting point 180°C.
Eksempel 10: 6- metyltio- 1- etyl-^- fenyl- 2( 1H)- chinazolinon Example 10: 6-methylthio-1-ethyl-^-phenyl-2(1H)-quinazolinone
a) éi^st^ltio^^-f eny_l = 2(1_H)=chinazolinon a) éi^st^ltio^^-f eny_l = 2(1_H)=quinazolinone
Analogt den i eksempel 9 a) beskrevne fremgangsmåte erholdes ved Analogous to the method described in example 9 a) is obtained by
erstatning av det deri anvendte 5-metyl-2-aminobenzofenon med en ekvivalent mengde 5-metyltio-2-aminobenzofenon den onskede forbindelse 6-metyltio-^-fenyl-2(1H)-chinazolinon med smeltepunkt 219-221°C. replacement of the 5-methyl-2-aminobenzophenone used therein with an equivalent amount of 5-methylthio-2-aminobenzophenone the desired compound 6-methylthio-^-phenyl-2(1H)-quinazolinone with melting point 219-221°C.
b) 6:mety_ltio=;[=ety_l^-f eny_l-2 (15 ):chinazolinon Analogt den i eksempel 1 beskrevne fremgangsmåte erholdes ved b) 6:methy_ltio=;[=ety_l^-f eny_l-2 (15 ):quinazolinone Analogous to the method described in example 1 is obtained by
erstatning av det deri anvendte 6,7-dimetyl-<!>+-fenyl-2(1H)-chinazolinon med en ekvivalent mengde é-metyltio-^-fenyl-2(1H)-chinazolinon og omkrystallisering av resten fra etylacetat den onskede forbindelse 6-metyltio-1 -etyl-lf-fenyl-2(1H)-chinazolinon - med smeltepunkt 1 50-151°C. replacement of the 6,7-dimethyl-<!>+-phenyl-2(1H)-quinazolinone used therein with an equivalent amount of ε-methylthio-^-phenyl-2(1H)-quinazolinone and recrystallization of the residue from ethyl acetate the desired compound 6-methylthio-1-ethyl-1f-phenyl-2(1H)-quinazolinone - with melting point 1 50-151°C.
Eksempel 11 : 1 - isopropyl- 7- hydroksy-^- feny1- 2( 1H)- chinazolinon Example 11: 1-isopropyl-7-hydroxy-^-phenyl-2(1H)-quinazolinone
a) ^l^stoks^-g-isoprog^laminobenzofenon a) ^l^stox^-g-isoprog^laminobenzophenone
En blanding av 9 g 2-amino-^-metoksybenzofenon, 15 g vannfritt A mixture of 9 g of 2-amino-^-methoxybenzophenone, 15 g anhydrous
kaliumkarbonat og ho ml 2-jodpropan oppvarmes i h dogn til koking under tilbakelop. Etter avkjoling av reaksjonsblandingen fortynnes med 200 ml benzen og vaskes med vann 2 ganger og 2 ganger med saltvann. Den organiske fase fraskilles, torres over v vannfritt natriumsulfat og inndampes i vakuum for vidtgående fjerning av benzen. Den erholdte olje loses i ca. 10 ml metylen-klorid og underkastes en kolonnekromatografering på ca. h- 00 g aluminiumoksyd, idet metylenklorid anvendes som elueringsmiddel. Den forste fraksjon inndampes i vakuum for fjernelse av metylen-klorid idet ^-metoksy-2-isopropylaminobenzofenon erholdes som en olje. potassium carbonate and 10 ml of 2-iodopropane are heated for 1 h to boiling under reflux. After cooling, the reaction mixture is diluted with 200 ml of benzene and washed twice with water and twice with salt water. The organic phase is separated, dried over v anhydrous sodium sulfate and evaporated in a vacuum for extensive removal of benzene. The obtained oil is unloaded for approx. 10 ml of methylene chloride and subjected to a column chromatography of approx. h- 00 g aluminum oxide, methylene chloride being used as eluent. The first fraction is evaporated in vacuo to remove methylene chloride, yielding ^-methoxy-2-isopropylaminobenzophenone as an oil.
k) ili§°EE2EY/ilZlm2t2ksy_-^-f^ny_l-2 0 H)=chinazolinon k) ili§°EE2EY/ilZlm2t2ksy_-^-f^ny_l-2 0 H)=quinazolinone
En blanding av 5?9 g M—metoksy-2-isopropylaminobenzofenon (erholdt etter den i eksempel 11 a) beskevne fremgangsmåte), 20 g uretan og 1,2 g zinkklorid oppvarmes i <*>f0 min. ved en temperatur på 200-215°C. Deretter tilsettes ca. 10 g uretan og 600 mg zinkklorid og oppvarmes på nytt ved en temperatur på 200-215°C i 1 time. Den erholdte blanding avkjoles til omtrent 100°C og fortynnes med kloroform. Deretter filtreres og filtratet vaskes forst med vann og deretter med saltvann. Den organiske fase fraskilles, torres over vannfritt natriumsulfat og inndampes i vakuum for vidtgående fjernelse av kloroform, idet det erholdes en oljeaktig rest som loses i en liten mengde på omtrent 10 ml metylenklorid. Etter fortynning med omtrent ho ml etylacetat og inndamping i vakuum erholdes 1-isopropyl-7-metoksy-!+-f enyl-2(1H)-chinazolinon med smeltepunkt 133-137°C. c) liiS°E£°EYilZ~5Z^E°^§^i^l?22Zil2(lH)=chinazolinon En blanding av 1 g 1-isopropyl-7-metoksy-^-fenyl-2(1H)-chinazolinon og 5 ml K8% bromhydrogensyre oppvarmes til koking under tilbakelop i 20 timer. Deretter fortynnes med 100 ml vann, innstilles alkalisk med vandig 2N natriumhydroksyd-lbsning (pH ^ 10) og ekstraheres 2 ganger med hver gang 50 ml etylacetat for fjernelse av ikke sure produkter. Den vandige fase fraskilles, behandles med 2N saltsyre og det dannede bunnfall frafiltreres. Etter omkrystallisering fra etanol erholdes 7-hydroksy-1-isopropyl-^-fenyl-2(1H)-chinazolinon med smeltepunkt 266-267°C. A mixture of 5.9 g of N-methoxy-2-isopropylaminobenzophenone (obtained according to the method described in example 11 a), 20 g of urethane and 1.2 g of zinc chloride is heated for <*>f0 min. at a temperature of 200-215°C. Then add approx. 10 g of urethane and 600 mg of zinc chloride and reheated at a temperature of 200-215°C for 1 hour. The resulting mixture is cooled to approximately 100°C and diluted with chloroform. It is then filtered and the filtrate is washed first with water and then with salt water. The organic phase is separated, dried over anhydrous sodium sulfate and evaporated in a vacuum for extensive removal of chloroform, obtaining an oily residue which is dissolved in a small amount of approximately 10 ml of methylene chloride. After dilution with approximately 100 ml of ethyl acetate and evaporation in a vacuum, 1-isopropyl-7-methoxy-!+-phenyl-2(1H)-quinazolinone with a melting point of 133-137°C is obtained. c) liiS°E£°EYilZ~5Z^E°^§^i^l?22Zil2(1H)=quinazolinone A mixture of 1 g of 1-isopropyl-7-methoxy-^-phenyl-2(1H)-quinazolinone and 5 ml K8% hydrobromic acid is heated to boiling under reflux for 20 hours. It is then diluted with 100 ml of water, made alkaline with aqueous 2N sodium hydroxide solution (pH ^ 10) and extracted twice with 50 ml of ethyl acetate each time to remove non-acidic products. The aqueous phase is separated, treated with 2N hydrochloric acid and the precipitate formed is filtered off. After recrystallization from ethanol, 7-hydroxy-1-isopropyl-^-phenyl-2(1H)-quinazolinone with melting point 266-267°C is obtained.
Eksempel 12: 1- etyl- 6- merkapto-^- feny1- 2( 1H)- chinazolinon Example 12: 1-ethyl-6-mercapto-^-phenyl-2(1H)-quinazolinone
En blanding av 3 g 6-metyltio-1-etyl-^--fenyl-2(1 H)-chinazolinon (fremstilt etter den i eksempel 10 beskrevne fremgangsmåte) og 25 ml h8% bromhydrogensyre oppvarmes i k dogn under tilbakelop. Deretter nøytraliseres med vandig 2N natriumhydroksydlosning og ekstraheres 2 ganger med hver gang 100 ml etylacetat. De organiske faser forenes, torres over vannfritt natriumsulfat, filtreres og inndampes i vakuum. Etter omkrystallisering av resten fra etylacetat erholdes 1-etyl-6-merkapto->+-fenyl-2(1H)-chinazolinon med smeltepunkt 200-20<1>+°C. A mixture of 3 g of 6-methylthio-1-ethyl-^--phenyl-2(1H)-quinazolinone (prepared according to the method described in example 10) and 25 ml of h8% hydrobromic acid is heated for 2 days under reflux. It is then neutralized with an aqueous 2N sodium hydroxide solution and extracted twice with 100 ml of ethyl acetate each time. The organic phases are combined, dried over anhydrous sodium sulphate, filtered and evaporated in vacuo. After recrystallization of the residue from ethyl acetate, 1-ethyl-6-mercapto->+-phenyl-2(1H)-quinazolinone with melting point 200-20<1>+°C is obtained.
Eksempel 13: 7- klor- 1- etyl- 6- metyl-^- fenyl- 2( 1H)- chinazolinon Example 13: 7-chloro-1-ethyl-6-methyl-^-phenyl-2(1H)-quinazolinone
a) 2=amino-*f-klor=5imety_lbenzofenon a) 2=amino-*f-chloro=5imethy_lbenzophenone
Til 1*4-2 g benzoylklorid tilsettes i lbpet av -§- time i små To 1*4-2 g of benzoyl chloride is added over the course of -§- hour in small increments
pors.j.oner til sammen 57 g 3-klor-<!>+-metylanilin ved 110°C. Den erholdte blanding oppvarmes 180°C, 1<>>+0 g zinkklorid tilsettes i fleres porsjoner i lopet av 1 time og det oppvarmes ved en temperatur på 225 - 230°C videre i 1^ time. Den erholdte blanding avkjoles til en temperatur på 120 - 130°C og en blanding portions to a total of 57 g of 3-chloro-<!>+-methylaniline at 110°C. The resulting mixture is heated to 180°C, 1<>>+0 g of zinc chloride is added in several portions over the course of 1 hour and it is heated at a temperature of 225 - 230°C for a further 1^ hours. The resulting mixture is cooled to a temperature of 120 - 130°C and a mixture
•av 150 ml eddiksyre, 100 ml vann og 150 ml konsentrert svovel-syre tilsettes. Deretter oppvarmes i 3 timer under tilbake- • of 150 ml of acetic acid, 100 ml of water and 150 ml of concentrated sulfuric acid are added. Then heated for 3 hours under reflux
lop, blandingen helles ut på 2 liter isblandet vann og ekstraheres 3 ganger med hver gang 300 ml metylenklorid. De organiske faser forenes, torres over vannfritt natriumsulfat, filtreres og inndampes I vakuum. Den erholdte oljeaktige rest fordeles mellom et av 500 ml 2N vandig natriumhydroksyd-ldsning og 300 lop, the mixture is poured into 2 liters of ice-cold water and extracted 3 times with 300 ml of methylene chloride each time. The organic phases are combined, dried over anhydrous sodium sulfate, filtered and evaporated in vacuo. The oily residue obtained is distributed between one of 500 ml of 2N aqueous sodium hydroxide solution and 300
ml metylenklorid sammensatt flytende system og den organiske fase vaskes forst med vann og deretter med saltvann. Deretter torres, filtreres og inndampes i vakuum, idet det erholdes et råprodukt. Dette renses ved omkrystallisering fra dietyleter/ pentan (1:2). Det herved erholdte 2-amino-<1>+-klor-5-metyl-benzofenon smelter ved 95 - 96°C. ml methylene chloride compound liquid system and the organic phase is washed first with water and then with salt water. It is then dried, filtered and evaporated in a vacuum, whereby a crude product is obtained. This is purified by recrystallization from diethyl ether/pentane (1:2). The 2-amino-<1>+-chloro-5-methyl-benzophenone thus obtained melts at 95 - 96°C.
b) 7-klor-6-metyl^^-fenyl-2(^H)-chinazolinon En blanding av 10 g 2-amino-<1>+-klor-5-metylbenzofenon og 10 g b) 7-chloro-6-methyl^^-phenyl-2(^H)-quinazolinone A mixture of 10 g of 2-amino-<1>+-chloro-5-methylbenzophenone and 10 g
urinstoff oppvarmes i 32" timer ved omtrent 180-200°C. Etter omkrystallisering av den faste rest fra dimetylsulfamid/vann (1:1) erholdes 7-klor-6-metyl-Lf-fenyl-2(1H)-chinazolinon som krystaller med smeltepunkt 310-315°C urea is heated for 32 hours at approximately 180-200°C. After recrystallization of the solid residue from dimethylsulfamide/water (1:1), 7-chloro-6-methyl-Lf-phenyl-2(1H)-quinazolinone is obtained as crystals with melting point 310-315°C
c) Zl^I°Elll!:5yil§I?§tyil^l£2nyiz2 (IH)-chinazolinon. c) Zl^I°Elll!:5yil§I?§tyil^l£2nyiz2 (1H)-quinazolinone.
1 ,1+ g natriumhydrid ( 50% suspensjon i mineralolje) tilsettes ved 1.1+ g of sodium hydride (50% suspension in mineral oil) is added by
romtemperatur en losning av 7 g 7-klor-6-metyl-<l>+-fenyl-2(1H)-chinazolinon i 200 ml dimetylsulfamid. Den erholdte blanding som inneholder natriumf orbindelsen av 7-klor-6-metyl-1+-f enyl-2 (1H)-chinazolinon, rores i 30 min. ved romtemperatur og tilsettes deretter 20 ml etyljodid. Deretter rores i 20 timer ved romtemperatur, room temperature a solution of 7 g of 7-chloro-6-methyl-<l>+-phenyl-2(1H)-quinazolinone in 200 ml of dimethylsulfamide. The resulting mixture containing the sodium compound of 7-chloro-6-methyl-1+-phenyl-2(1H)-quinazolinone is stirred for 30 min. at room temperature and then add 20 ml of ethyl iodide. Then stir for 20 hours at room temperature,
blandingen uthelles i 1 liter isblandet vann, det utfallende bunnfall frafiltreres, torres og omkrystalliseres fra metylen-klorid/eter (1:5). Det herved erholdte 7-klor-1-etyl-6-metyl-<l>+-fenyl-2(1H)-chinazolinon smelter ved 1 85°C~1 87°C. the mixture is poured into 1 liter of ice-cold water, the resulting precipitate is filtered off, dried and recrystallized from methylene chloride/ether (1:5). The 7-chloro-1-ethyl-6-methyl-<l>+-phenyl-2(1H)-quinazolinone thus obtained melts at 1 85°C~1 87°C.
Eksempel 1*+ : Example 1*+ :
Analogt den i eksempel 1 b) beskrevne fremgangsmåte erholdes ved omsetning av ekvivalente mengder av natriumforbindelsene av de i det folgende beskrevne utgangsforbindelser med etyljodid de folgende sluttforbindelser: Utgangsforbindelser Sluttforbindelser Natriumforbindelser av a) 7-metyl->+-fenyl-2(1H)- 1 -etyl-7-metyl-^-fenyl-2(1H)-chinazolinon chinazolinon med smp. 160-162 C (omkrystallisering fra etylacetat. ) b) 7-nitro-<l>+-fenyl-2(1H)- 1-etyl-7-nitro-)+-fenyl-2(1H)-chinazolinon chinazolinon med smp. 200-203°C (omkrystallisering fra etylacetat) c) 6 ,7-dimetoksy-^-f enyl- 1-etyl-6 ,7-dimetoksy-!+-f enyl-2(1H)-chinazolinon 2(1H)-chinazolinon med smp. 175 C. (omkrystallisering fra dietyleter) Ved omsetningen med metyljodid kommer man frem til Utgangsforbindelser Sluttforbindelser Natriumforbindelser av d) 7-metyl-<I>4--fenyl-2(1H)- 1 ,7-dimetyl-*4--fenyl-2(1H)-chinazolinon chinazolinon med smp. 171-172 C (omkrystallisering fra etylacetat) e) 6,7-dimetoksy-^-fenyl- 1-metyl-6,7-dimetoksy-^-fenyl 2(1H)-chinazolinon -2(1H)-chinazolinon med smp. Analogous to the method described in example 1 b), the following end compounds are obtained by reacting equivalent amounts of the sodium compounds of the starting compounds described below with ethyl iodide: Starting compounds End compounds Sodium compounds of a) 7-methyl->+-phenyl-2(1H)- 1 -ethyl-7-methyl-^-phenyl-2(1H)-quinazolinone quinazolinone with m.p. 160-162 C (recrystallization from ethyl acetate. ) b) 7-nitro-<l>+-phenyl-2(1H)- 1-ethyl-7-nitro-)+-phenyl-2(1H)-quinazolinone quinazolinone with m.p. . 200-203°C (recrystallization from ethyl acetate) c) 6,7-dimethoxy-^-phenyl-1-ethyl-6,7-dimethoxy-!+-phenyl-2(1H)-quinazolinone 2(1H)- quinazolinone with m.p. 175 C. (recrystallization from diethyl ether) The reaction with methyl iodide leads to Starting compounds Final compounds Sodium compounds of d) 7-methyl-<I>4--phenyl-2(1H)- 1 ,7-dimethyl-*4--phenyl -2(1H)-quinazolinone quinazolinone with m.p. 171-172 C (recrystallization from ethyl acetate) e) 6,7-dimethoxy-^-phenyl-1-methyl-6,7-dimethoxy-^-phenyl 2(1H)-quinazolinone -2(1H)-quinazolinone with m.p.
197-198 C (omkrystallisering fra etylacetat) 197-198 C (recrystallization from ethyl acetate)
Eksempel 15: Example 15:
Analogt de eksempåA b) eller 5 b) beskrevne fremgangsmåter fås Analogous to the methods described in example A b) or 5 b) are obtained
ved omsetning av ekvivalente mengder av de i det folgende beskrevne utgangsforbindelser med uretan de folgende sluttforbindelser: by reacting equivalent quantities of the starting compounds described below with urethane the following final compounds:
Utgangsforbindelser Sluttforbindelser Output connections End connections
a) 5-metoksy-2-etylamino- 1 -etyl-é-metoksy-^-fenyl-benzofenon 2(1H)-chinazolinon med smp. a) 5-methoxy-2-ethylamino-1-ethyl-é-methoxy-^-phenyl-benzophenone 2(1H)-quinazolinone with m.p.
138-1*f20C 138-1*f20C
b) If-klor-5-metyl-2-etyl- 1-etyl-6-metyl-7-klor-If-aminobenzofenon fenyl-2(1H)-chinazolinon b) If-chloro-5-methyl-2-ethyl-1-ethyl-6-methyl-7-chloro-If-aminobenzophenone phenyl-2(1H)-quinazolinone
med smp. 185-187 C with m.p. 185-187C
c) h,5-dimetyl-2-etylamino- 1-etyl-6,7-dimetyl-^-fenyl-benzofenon 2(1H)-chinazolinon med smp. c) h,5-dimethyl-2-ethylamino-1-ethyl-6,7-dimethyl-^-phenyl-benzophenone 2(1H)-quinazolinone with m.p.
176-1809C. 176-1809C.
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70793268A | 1968-02-26 | 1968-02-26 | |
US74180468A | 1968-07-01 | 1968-07-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO128962B true NO128962B (en) | 1974-02-04 |
Family
ID=27107992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO00603/69A NO128962B (en) | 1968-02-26 | 1969-02-14 |
Country Status (10)
Country | Link |
---|---|
BG (4) | BG17596A3 (en) |
DK (3) | DK128007B (en) |
ES (1) | ES364005A1 (en) |
IE (1) | IE33434B1 (en) |
IL (1) | IL31683A (en) |
NO (1) | NO128962B (en) |
OA (1) | OA03389A (en) |
PL (2) | PL79534B1 (en) |
RO (2) | RO57857A (en) |
SE (1) | SE353911B (en) |
-
1968
- 1968-10-28 PL PL1968129788A patent/PL79534B1/pl unknown
-
1969
- 1969-02-14 NO NO00603/69A patent/NO128962B/no unknown
- 1969-02-17 DK DK86669AA patent/DK128007B/en unknown
- 1969-02-19 SE SE02281/69A patent/SE353911B/xx unknown
- 1969-02-24 PL PL1969131919A patent/PL70441B1/pl unknown
- 1969-02-24 IE IE238/69A patent/IE33434B1/en unknown
- 1969-02-24 IL IL31683A patent/IL31683A/en unknown
- 1969-02-24 ES ES364005A patent/ES364005A1/en not_active Expired
- 1969-02-25 BG BG13123A patent/BG17596A3/xx unknown
- 1969-02-25 BG BG13126A patent/BG17597A3/xx unknown
- 1969-02-25 RO RO64032A patent/RO57857A/ro unknown
- 1969-02-25 BG BG13132A patent/BG17595A3/xx unknown
- 1969-02-25 BG BG11741A patent/BG17592A3/xx unknown
- 1969-02-25 RO RO59192A patent/RO55407A/ro unknown
- 1969-02-26 OA OA53522A patent/OA03389A/en unknown
-
1970
- 1970-03-04 DK DK108170AA patent/DK128564B/en unknown
- 1970-03-04 DK DK107870AA patent/DK127187B/en unknown
Also Published As
Publication number | Publication date |
---|---|
DK128564B (en) | 1974-05-27 |
BG17592A3 (en) | 1973-11-10 |
RO57857A (en) | 1975-02-15 |
DK127187B (en) | 1973-10-01 |
IE33434L (en) | 1969-08-26 |
OA03389A (en) | 1970-12-15 |
RO55407A (en) | 1974-03-01 |
BG17595A3 (en) | 1973-11-10 |
BG17596A3 (en) | 1973-11-10 |
BG17597A3 (en) | 1973-11-10 |
PL70441B1 (en) | 1974-02-28 |
IL31683A0 (en) | 1969-04-30 |
SE353911B (en) | 1973-02-19 |
IL31683A (en) | 1974-09-10 |
PL79534B1 (en) | 1975-06-30 |
IE33434B1 (en) | 1974-06-26 |
DK128007B (en) | 1974-02-18 |
ES364005A1 (en) | 1971-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1041108A (en) | Antihistaminic imidazoles | |
NO177304B (en) | Analogous Process for Preparation of Therapeutically Active Benzimidazole Derivatives | |
NO124032B (en) | ||
GB2082580A (en) | Tricyclic imidazole derivatives | |
NO151966B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE IMIDAZOLE-5-ACETIC ACID DERIVATIVES | |
US3435049A (en) | Nitroimidazole derivatives | |
NO822918L (en) | NEW IMIDAZOKINAZOLINE DERIVATIVES. | |
CA1103245A (en) | Process for the manufacture of novel oxadiazolopyrimidine derivatives | |
NO764039L (en) | ||
NO128962B (en) | ||
PL82659B1 (en) | 7-(imidazolinyl-(2)-amino)-indazoles[us3847934a] | |
US3819627A (en) | 1-substituted-3,4-dihydro-2(1h)-quinazolinones | |
Badger et al. | Azaindoles. I. Introduction | |
NZ199733A (en) | 4-aroylimidazol-2-ones | |
US3341549A (en) | 2-sulfonyl-and 2-cyano-5-nitroimidazoles | |
US3764600A (en) | 1-substituted-quinazoline-2(1h)-thiones | |
EP0391254A2 (en) | Novel thiouracil derivatives pharmaceutical compositions containing them and process for preparing same | |
JPH0365349B2 (en) | ||
IE46279B1 (en) | Sulphamoylbenzoic acids | |
NO150281B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE 3,4,5,6-TETRAHYDRO (1,3) THIAZOLO (3,4-A) ISOQINOLINE DERIVATIVES | |
US3390150A (en) | Process for the preparation of 1-(beta-hydroxyethyl)-5-nitroimidazole-2-carboxylic acid gamma-lactone | |
EP0244352A2 (en) | Pyrido[4,3-d]pyrimidine derivatives | |
IL32504A (en) | Quinazoline-2(1h)-thione derivatives,their preparation and pharmaceutical preparations containing them | |
EP0052959B1 (en) | Production of purine derivatives and intermediates therefor | |
NO157142B (en) | 6-phenyl-hydrazono-6,7,8,9-tetrahydro-11H-pyrido (2,1-b) quinazolin-11-ones. |